Drug Type Small molecule drug |
Synonyms CBG-040591 |
Target |
Mechanism IL-17RA antagonists(Interleukin-17 receptor A antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Preclinical | ES | 01 Dec 2020 |